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Abstract 
Background: Toxoplasmosis is a disease caused by infection of Toxoplasma gondii 
which may cause a life-threatening condition in immunocompromised patients, for 
example, Toxoplasma encephalitis (TE). It is challenging to diagnose Toxoplasma as 
a cause of central nervous system (CNS) infection in HIV patient, so we need an 
alternative method, which is a PCR detection of Toxoplasma gondii B1 gene.  
Objective: This research aimed to find association between PCR methods for 
Toxoplasma gondii B1 gene and anti-Toxoplasma IgG from cerebral spinal fluid 
patient HIV AIDS. 
Methods: A cross-sectional study was conducted to Cerebrospinal fluid (CSF) 
samples of HIV patients with neurological symptoms to determine Toxoplasma gondii 
infection using nested PCR methods for the B1 gene and detection of anti-Toxoplasma 
IgG. 
Results: 88 CSF samples from HIV patients tested using nested PCR showed 23 
samples (26,1%) were positive. Serologic test for IgG Toxoplasma showed 34 samples 
were positive (28,6%). There was a significant correlation (p=0.000(<0.05) between 
PCR result and a serologic test for IgG Toxoplasma. 
Conclusion: Nested PCR methods to detect B1 gene increased the accuracy of 
diagnosis for toxoplasma encephalitis. 
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INTRODUCTION 
Toxoplasma gondii infection comes from the 
protozoan parasite, which is predicted to infect about 
one-third of the world’s population.1 The prevalence of 
toxoplasmosis in Jakarta is estimated to reach 70%.2 In 
normal condition, T. gondii infection is asymptomatic, 
but in some immunocompromised individuals, a 
bradyzoite-containing cyst can rupture and reactivate the 
latent infection-causing toxoplasma encephalitis (TE).3 
Toxoplasma encephalitis (TE) attacks the central 
nervous system (CNS), especially in patients with severe 
HIV infection, even though the incidence of this disease 
decreases because of antiretroviral drugs. It is predicted 
that about 10-50% of AIDS patients with toxoplasmosis 
will continue to be TE.4  
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In Indonesia, TE is still the main CNS disorder in AIDS 
patients followed after Tuberculous meningitis.5 
A definitive diagnosis of TE can be provided by brain 
biopsy and finding T. gondii tachyzoites. The 
examination is an invasive procedure and associated with 
a significant increase in morbidity and mortality. A 
tentative diagnosis of this disease only based on CNS 
signs and symptoms, the positive result of anti-T. gondii 
antibody and typical single lesions  or multiple ring-
enhancing lesions in the brain detected by Computed 
Tomography (CT) and Magnetic Resonance Imaging 
(MRI).1,6 Disadvantages of serologic test for Toxoplasma 
were the serologic result of anti-Toxoplasma antibody 
should be interpreted carefully and it can be failed to 
detect anti-Toxoplasma antibody in the early phase of 
infection.7,8 Serologic test also unable to detect 
Toxoplasma infections in immunocompromised patients, 
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because there is a disturbance in immunoglobulin 
production, where anti-Toxoplasma IgG only appear in 
30% HIV patients with active toxoplasmosis, and only 
2% shows positive for IgM.9,10 
The molecular diagnosis using PCR for various 
clinical specimens become a powerful tool for detection 
of T. gondii DNA.9,11 The problem is  the sensitivity of 
this technique is not yet established.7,12 The utilization of 
PCR for detecting T. gondii in CSF has been done. PCR 
can detect T. gondii DNA using primer for the B1 gene, 
which is frequently used and has remarkable sequence 
conservation (99.5%) of the B1 gene. It also has been 
confirmed by analysis of DNA sequences from many 
clonal strains.9 Some studies found that PCR sensitivity 
to detect B1 gene is 83.3%, and its specificity reached 
95.7%12, and another experiment shows 100% 
sensitivity and 94.9% specificity13.  
The aim of the present study is to find association 
between of PCR methods for Toxoplasma gondii B1 
gene and anti-Toxoplasma IgG from cerebral spinal fluid 
patient HIV AIDS. 
 
MATERIALS AND METHODS  
This study was held in the Laboratory of Parasitology 
Faculty of Medicine Universitas Indonesia, November 
2015 - January 2016. A cross-sectional study was 
performed to determine Toxoplasma gondii infection 
from cerebrospinal fluid (CSF) of HIV patients with 
neurological symptoms. The inclusion criteria were all 
cerebrospinal fluid samples of HIV patients with 
neurological symptoms available in the Laboratory of 
Parasitology Faculty of Medicine Universitas Indonesia. 
The sampling technique used in this study was 
consecutive sampling, which means every CSF was 
included as a sample until minimal samples were 
achieved.  
 
DNA isolation from CSF and Amplification of 
targeting DNA 
DNA from CSF samples were extracted using DNA 
mini kit the QIAGEN method with 80μL AE buffer. T. 
gondii was detected using B1 gene amplification. The 
amplification was performed individually in 20μL of 
reaction mixture containing 1x PCR buffer, 1.5 mM 
MgCl2, 200 µM each were dNTP (dATP, dGTP, dTTP, 
dCTP), 250 µM for each primer, and 1.5 U Taq 
polymerase. The other conditions were optimized 
carefully before the study was started. Primers used were 
the same primers as the previous study14 in gene 
amplification, as seen below.  
As many as 3 µl extracting DNA from CSF samples 
were added to the mixture to make the template for the 
first PCR round, followed by 2 µl DNA results from the 
first PCR round was used as templates for the second 
PCR round. The reaction condition was modified from 
previous study to optimize the PCR condition.12 PCR 
steps to amplify target gene were: initialization step, 
which consisted of heating temperature at 95oC for 7 
minutes. Denaturation step continued as heating the 
reaction to 95oC for 1 minute, annealing step at 48oC for 
1 minute, and followed by extension by extension step in 
72oC for 2 minutes, and repeated for 35 times/cycles. The 
reaction was ended at 72oC extension for 7 minutes.  
Amplification result was separated using agarose gel 
electrophoresis in 0.5x TBE (0.05M Tris Base, 0.05M 
borate acid, and 0.001 M pH 8.5 EDTA) buffer and 
stained with SYBR green. Electrophoresis was run at 100 
volts for 50 minutes, and then the result was viewed 
under UV light. 
Each PCR reactions included one negative control 
(pure water) and one positive control (from DNA 
extraction of T. gondii tachyzoites). 
 
IgG anti-Toxoplasma Examination from CSF 
IgG anti-Toxoplasma examination uses the Anti-
Toxoplasma gondii ELISA (IgG) EUROIMMUN ™ kit 
(Cat number EI 2410-9601G, Lűbeck, Germany) and 
follows the procedure listed in the kit. 
 
Statistical analysis 
The result of PCR was categorized as positive or 
negative, and the result of serologic titer for IgG-
Toxoplasma was divided into three groups based on 
Derouin et al.15 Those groups were negative (<11IU), low 
titers (≥11-150IU) and high titers (>150IU). These two 
different methods to be statistically analyzes using Chi-
Square test for trend.  
 
Ethical aspect 
Ethical approval for the study was obtained from The 
Ethics Committee of Faculty of Medicine, University of 
Indonesia, which approved all protocol in this study. 
 
RESULTS 
This study using CSF samples from HIV patients with 
neurological disorders for example meningitis. There 
were 88 CSF available from Parasitology Department 
Faculty of Medicine Universitas Indonesia for 
examination. As many as 49 samples came with clinical 
diagnosis i.e. Tuberculosis meningoencephalitis (TB 
ME, 46%), Toxoplasma encephalitis or TB ME (28%), 
Cryptococcus meningitis or TB ME (12%) and no 
clinical diagnosis for the rest. The samples originated 
from 90% male and 5% female with age ranged 20 to 50 
years old.  
 
 
PCR examination results. 
B1 gene detection using nested PCR method had 
shown that 23 out of 88 samples were positive. Positive 
results were characterized by obtaining a specific band of 
DNA Toxoplasma gondii at 131 bp whereas negative 
result showed no band at all (Figure 1). 
 
PCR Round Forward PCR primers (5’ -3’) Reverse PCR primers (5’-3-) 
First GGAACTGCATCCGTTCATGAG GGCGACCAATCTGCGAATACACC 
Second TGCATAGGTTGCAGTCACTG  TCTTTAAAGCGTTCGTGGTC  
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PCR examination and serologic test using ELISA 
Table 1 shows there were 23 CSF samples (26.1%) 
positive by nested PCR of the B1 gene while the anti-
Toxoplasma IgG assay showed 34 samples positive 
(38,6%). Statistical analysis using Chi-Squared Test 
revealed a significant association (p=0.000, p<0.05) 
between the two methods and a significant positive 
correlation between PCR and IgG results (Spearman 
correlation =0.537 and p<0.001)  
A higher proportion of positive PCR among those 
with higher anti-Toxoplasma IgG; 4 out of 54 (7.4%) 
samples negative for anti-Toxoplasma IgG, 12 out of 25 
(48%) samples with low anti-Toxoplasma IgG and 7 out 
of 9 (77.7%) samples with high anti- Toxoplasma IgG. It 
was clear that positive PCR results had a trend to 
associate to higher IgG concentration, as well as the 
negative PCR results to very low and negative IgG titer. 
 
DISCUSSION 
In this study, the nested PCR for Toxoplasma gondii B1 
gene could be alternative to diagnose Toxoplasma 
encephalitis in HIV patients. This study showed that 
positive samples showed higher titer of anti-Toxoplasma 
IgG. 
Nested PCR was chosen as a method in this research, 
due to nested PCR had a respectable sensitivity.16–18 
Choosing the B1 gene as a target was due to its 
amplification has some advantages, such as higher 
sensitivity than another targeting gene.19 B1 gene did not 
amplify DNA from any other bacterial and fungal, and 
its sensitivity was not changed because of different DNA 
count in human and increase in protein. This gene also 
had good gene conservation.20 Moreover, the B1 gene 
was the most often gene used in toxoplasmosis molecular 
study.12–14  
From 88 samples in this study, 26.1% showed 
positive PCR results. This finding supported the previous 
experiment that the sensitivity to diagnose TE 
(Toxoplasma encephalitis) from CSF was about 17—
100%.12 It should be noted that PCR sensitivity was relied 
on some factors like the chemical and physical condition 
of reaction, targeting DNA concentration, choosing 
primer, and DNA extraction method. In this study, there 
was a limitation in sample volume, which was a little that 
could affect the DNA concentration then affect the 
sensitivity of the test.21 Nevertheless, this data showed 
that the PCR procedure in this study could be used to 
diagnose Toxoplasma encephalitis. 
IgG was selected as the primary test to detect 
Toxoplasma infection because most of the HIV patients 
with CNS disorder originated from reactivation of past 
Toxoplasma infection. The previous study also 
confirmed the predominance of IgG antibodies in 
immune response to T.gondii.22 To assess the active 
infection stage, molecular detection by PCR was chosen 
instead of anti-Toxoplasma IgM which may not be 
produced due to the immunocompromised state.  
IgG examination results showed a higher proportion 
of patients positive for anti-Toxoplasma IgG in 
comparison to the PCR result (38.6 % vs 26.1%) 
suggesting that most patients suffered from Toxoplasma 
reactivation. This high positive percentage did not mean 
 
Figure 1. Optimization of DNA extraction results. From left to right: ladder 50bp, tachyzoites extraction using 
QIAGEN minikit method (Tq), boiling method for tachyzoites (Tb), negative control 1 (H20), negative control 2 
(H20), direct method for CSF (NT), minikit method for CSF (Mini kit), boiling method for CSF (boiling) 
 
Table 1. Comparison between PCR-based method and serologic test for IgG anti-Toxoplasma from CSF 
    Serologic test for IgG anti Toxoplasma Total % 
  
Negative % 
Low 
Titer 
IgG 
% 
High 
Titer 
IgG 
%   
PCR 
results 
Positive 4 7,4% 12 48  % 7 77.8% 23 26.1 
Negative 50 17% 13 56.8% 2 22.22% 65 73.9 
  Total 54 100% 25 100 % 9 100% 88 100 
Negative titer below: 11 IU, Low titer IgG anti Toxoplasma: ≥11-150 IU and high titer IgG anti Toxoplasma >150 IU 
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that the patients were actively infected, as a small 
proportion of patients with negative anti Toxoplasma 
IgG, showed positive PCR result. Toxoplasma serology 
test could fail to detect anti-Toxoplasma antibody 
especially in the early phase of primary Toxoplasma 
infection. Toxoplasma serology test could fail to detect 
anti-Toxoplasma antibody especially in the early phase 
of primary infection. This situation might be due to the 
antibody that was not produced until several weeks of 
parasitemia exceeded.3 
This result is also consistent with the previous study4. 
That study used the same targeting gene as this study. 
The difference was the initial CSF volume and PCR 
method used. Ganiem et al. used 7 ml CSF and real-time 
PCR method. Another difference was the specimen used. 
In this study, we used CSF as samples, but the previous 
one used serum from HIV patients as samples. 
This research came with the result that positive PCR 
had a trend to show higher IgG concentration. The 
statistical analysis was showing the significant positive 
correlation between PCR test and IgG status. Other 
investigation also showed similar results4. Nevertheless, 
it should be noted that in this research, several samples 
that show higher titer with negative PCR results. 
The use of PCR will tell us the active stage of 
Toxoplasma infection while measuring one time anti 
Toxoplasma IgG will not be able to tell active infection, 
however we tried to find any correlation between those 
two tests and got R=0.537 suggesting at some point IgG 
anti-Toxoplasma may associate to active infection 
however there is a need for a second test to confirm it, 
and PCR is currently the best. According to Vidal JE et 
al, all patients with cerebral toxoplasmosis presented 
positive result of PCR B1  (sensitivity 100%  and 
specificity  94.4%) from CSF sample while poor 
performance was obtained when using blood samples 
(100% specificity and 25% sensitivity). 13,23   
The limitation in this study, beside the lack of sample 
volume, several samples were the old collections saved 
for a long time. Samples in this study were part of 
previous study on detection of Cryptococcus in 
neuroAIDS and have undergone the freeze-thawing 
process for two times. As very small left over of the cells, 
this may also cause negative PCR result. This sample 
condition resulted in DNA degradation and caused 
several IgG results with high titer could not be detected 
by PCR. It is consistent with the previous study that 
reached 33.33% sensitivity from PCR. The sensitivity 
was increasing up to 50% if lumbal puncture was done 
one week before therapy and directly examined.21,24  
From these results of Toxoplasma PCR examination 
from CSF, it was clearly stated that the high sensitivity 
could rule out other differential diagnosis. This test 
could be done to complete other supporting tests such as 
radiology, serology examination to diagnose active 
infection of Toxoplasma encephalitis. 
A more complex experimental design is needed to 
include several HIV and AIDS centers and more samples 
to find the significant correlation between variables. 
Future study between PCR, serology of anti-Toxoplasma 
IgG and clinical information is needed and should 
involve several HIV AIDS centers with larger number of 
samples. 
 
CONCLUSION 
Nested PCR of B1 gene Toxoplasma gondii from CSF 
could be used to diagnose Toxoplasma Encephalitis in 
HIV patients. The positive PCR results tend to have 
higher anti-Toxoplasma IgG titer. This study showed that 
PCR methods to detect B1 gene was helpful for 
increasing the accuracy of diagnosis for Toxoplasma 
Encephalitis. 
 
ACKNOWLEDGMENTS  
We would thank adjunct Professor Retno 
Wahyuningsih who has been willing to assist in 
providing research samples. 
 
REFERENCES  
1. Luma HN, Tchaleu BC, Mapoure YN, Temfack E, 
Doualla MS, Halle MP, et al. Toxoplasma 
encephalitis in HIV/AIDS patients admitted to the 
Douala general hospital between 2004 and 2009: a 
cross sectional study. BMC Res Notes. 
2013;6(1):146.  
2. Terazawa A, Muljono R, Susanto L, Margono SS, 
Konishi E. High Toxoplasma antibody prevalence 
among inhabitants in Jakarta, Indonesia. Jpn J Infect 
Dis. 2003;56(27):107–9.  
3. Munoz M, Liesenfeld O, Heimesaat MM. 
Immunology of Toxoplasma gondii. Immunol Rev. 
2011;240(1):269–85.  
4. Ganiem AR, Dian S, Indriati A, Chaidir L, 
Wisaksana R, Sturm P, et al. Cerebral Toxoplasmosis 
Mimicking Subacute Meningitis in HIV-Infected 
Patients; a Cohort Study from Indonesia. PLoS Negl 
Trop Dis. 2013;7(1):e1994.  
5. Imran D, Estiasari R, Maharani K, Sucipto, Lestari 
DC, Yunus RE, et al. Presentation, etiology, and 
outcome of brain infections in an Indonesian 
hospital. Neurol Clin Pract. 2018 Oct 1;8(5):379 LP-
388.  
6. Robert-Gangneux F, Dardé ML. Epidemiology of 
and diagnostic strategies for toxoplasmosis. Clin 
Microbiol Rev. 2012;25(2):264–96.  
7. Ferreira MS, Borges AS. Some Aspects of Protozoan 
Infections in Immunocompromised Patients: A 
Review. Mem Inst Oswaldo Cruz. 2002;97(4):443–
57.  
8. Meira CS, Vidal JE, Costa-Silva TA, Frazatti-
Gallina N, Pereira-Chioccola VL. Immunodiagnosis 
in cerebrospinal fluid of cerebral toxoplasmosis and 
HIV-infected patients using Toxoplasma gondii 
excreted/secreted antigens. Diagn Microbiol Infect 
Dis. 2011;71(3):279–85.  
9. Alfonso Y, Fraga J, Cox R, Bandera F, Pomier O, 
Fonseca C, et al. Comparison of four DNA extraction 
methods from cerebrospinal fluid for the detection of 
Toxoplasma gondii by polymerase chain reaction in 
AIDS patients. Med Sci Monit. 2008;14(3):MT1-6.  
10. Lin MH, Chen TC, Kuo TT, Tseng CC, Tseng CP. 
Real-time PCR for quantitative detection of 
Toxoplasma gondii. J Clin Microbiol. 
2000;38(11):4121–5.  
 
 
 
 
66 
 
 
Journal of Biomedicine and Translational Research, 5 (2) 2019, 62-66 
11. Mesquita RT, Ziegler AP, Hiramoto RM, Vidal JE, 
Pereira-Chioccola VL. Real-time quantitative PCR 
in cerebral toxoplasmosis diagnosis of Brazilian 
human immunodeficiency virus-infected patients.J 
Med Microbiol. 2010;59(Pt 6):641–7.  
12. Alfonso Y, Fraga J, Fonseca C, Jiménez N, Pinillos 
T, Dorta-Contreras AJ, et al. Molecular diagnosis of 
Toxoplasma gondii infection in cerebrospinal fluid 
from AIDS patients. Cerebrospinal Fluid Res. 
2009;6:2.  
13. Vidal JE, Colombo FA, Penalva AC, Oliveira D, 
Focaccia R, Lucia V, et al. PCR Assay Using 
Cerebrospinal Fluid for Diagnosis of Cerebral 
Toxoplasmosis in Brazilian AIDS patients PCR 
Assay Using Cerebrospinal Fluid for Diagnosis of 
Cerebral Toxoplasmosis in Brazilian AIDS patients. 
2004;42(10):4765–8.  
14. Alfonso Y, Fraga J, Cox R, Jiménez N, Capó V, 
Pomier O, et al. Conventional polymerase chain 
reaction for the diagnosis of neurotoxoplasmosis: 
comparison of three sets of primers for the B1 gene 
using CSF samples. Diagn Microbiol Infect Dis. 
2013;75(2):150–4.  
15. Derouin F, Leport C, Pueyo S, Morlat P, Letrillart 
B, Chene G, et al. Predictive value of Toxoplasma 
gondii antibody titres on the occurrence of 
toxoplasmic encephalitis in HIV-infected patients. 
ANRS 005/ACTG 154 Trial Group. AIDS. 1996 
Nov;10(13):1521–7.  
16. Hierl T, Reischl U, Lang P, Hebart H, Stark M, 
Kyme P, et al. Preliminary evaluation of one 
conventional nested and two real-time PCR assays 
for the detection of Toxoplasma gondii in 
immunocompromised patients. J Med Microbiol. 
2004;53(7):629–32.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17. Teixeira LE, Kanunfre KA, Shimokawa PT, Targa 
LS, Rodrigues JC, Domingues W, et al. The 
performance of four molecular methods for the 
laboratory diagnosis of congenital toxoplasmosis in 
amniotic fluid samples. Rev Soc Bras Med Trop. 
2013;46(5): 584-8.  
18. Vitale M. A High Sensitive Nested PCR for 
Toxoplasma gondii Detection in Animal and Food 
Samples. J Microb Biochem Technol. 
2013;05(02):39–41.  
19. Jones CD, Okhravi N, Adamson P, Tasker S. 18S 
rDNA Genes of T . Gondii in Aqueous Humor AND. 
Invest Ophthalmol. 2000;41(3):634–44.  
20. 20.  Grigg ME, Boothroyd JC. Rapid identification 
of virulent type I strains of the protozoan pathogen 
Toxoplasma gondii by PCR-restriction fragment 
length polymorphism analysis at the B1 gene. J Clin 
Microbiol. 2001;39(1):398–400.  
21. Bastien P, Procop GW, Reischl U. Quantitative real-
time PCR is not more sensitive than “ conventional” 
PCR. J Clin Microbiol. 2008;46(6):1897–900.  
22. Paulo S. Toxoplasma- Specific IgG Subclass 
Antibody response in Cerebrospinal Fluid. 
2015;57(5):439–42.  
23. Ajzenberg D, Lamaury I, Demar M, Vautrin C, Cabié 
A, Simon S, et al. Performance Testing of PCR 
Assay in Blood Samples for the Diagnosis of 
Toxoplasmic Encephalitis in AIDS Patients from the 
French Departments of America and Genetic 
Diversity of Toxoplasma gondii : A Prospective and 
Multicentric Study. 2016;1–17.  
24. Cingolani A, Luca ADE, Ammassari A, Murri R, 
Linzalone A, Grillo R, et al. PCR detection of 
Toxoplasma gondii DNA in CSF for the differential 
diagnosis of AIDS-related focal brain lesions. 
2015;45(1996):7–11.  
 
